Showing 751-760 of 1564 results for "".
- Immune Cells Identified as Key Players in Brain Healthhttps://reachmd.com/news/immune-cells-identified-as-key-players-in-brain-health/2462392/Using novel genetic and genomic tools, researchers at the Icahn School of Medicine at Mount Sinai have shed light on the role of immune cells called macrophages in lipid-rich tissues like the brain, advancing our understanding of Alzheimer's and other diseases. The study,
- New Cell Therapy Shows Promise with ARDS Patientshttps://reachmd.com/news/new-cell-therapy-shows-promise-with-ards-patients/2457085/Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with acute respiratory distress syndrome (ARDS) resulting from severe Covid-19. Published in the journal Nature Communications, Professor
- Biomarker to Predict Preeclampsia in Sickle Cell Pregnancies: A Diagnostic Breakthroughhttps://reachmd.com/news/biomarker-to-predict-preeclampsia-in-sickle-cell-pregnancies-a-diagnostic-breakthrough/2484022/Placental Growth Factor (PlGF) accurately predicts preeclampsia in pregnancies complicated by sickle cell disease, offering a potential shift in prenatal risk stratification. A
- The Evolving Role of JAK Inhibitors: Upadacitinib’s Impact on Giant Cell Arteritishttps://reachmd.com/news/the-evolving-role-of-jak-inhibitors-upadacitinibs-impact-on-giant-cell-arteritis/2475405/Upadacitinib, a Janus kinase (JAK) inhibitor, has shown efficacy in managing giant cell arteritis by achieving sustained remission in clinical trials, potentially providing an alternativ
- Advancing Pediatric Sickle Cell Protocols: Innovations in Emergency Care at MUSChttps://reachmd.com/news/advancing-pediatric-sickle-cell-protocols-innovations-in-emergency-care-at-musc/2474887/Children with sickle cell disease presenting to the emergency department with fever often experience delays in assessment and variability in interventions, highlighting the need for stan
- 'Dual-Target' Cell Therapy Appears to Shrink Brain Tumors, Research Findshttps://reachmd.com/news/dual-target-cell-therapy-appears-to-shrink-brain-tumors-research-finds/2462328/Credit: Anna Shvets from Pexels Targeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy
- Scientists Identify Potential New Immune System Target to Head Off the Spread of Breast Cancer Cellshttps://reachmd.com/news/scientists-identify-potential-new-immune-system-target-to-head-off-the-spread-of-breast-cancer-cells/2468059/In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the closest neighbors of breast cancer cells that are likely to spread. The researchers say the finding, focused on a white bl
- Sodium Channels in Breast Cancer Cells a Promising Target for Future Treatments, Study Revealshttps://reachmd.com/news/sodium-channels-in-breast-cancer-cells-a-promising-target-for-future-treatments-study-reveals/2467549/Sodium channels in breast cancer cells a promising target for future treatments, study reveals Posted on 25 July 2024 A new study on live tissue cells is the first to reveal how channels that allow sodium to enter into breast cancer cells enable tumours to grow and
- Urolithin C alleviates Pancreatic β-Cell Dysfunction in Type 1 Diabetes by Activating Nrf2 Signalinghttps://reachmd.com/news/urolithin-c-alleviates-pancreatic-cell-dysfunction-in-type-1-diabetes-by-activating-nrf2-signaling/2457377/Type 1 diabetes (T1D) is an autoimmune disorder that destroys insulin-generating pancreatic β-cells. Preserving pancreatic β-cell function is important for treating T1D. Our study aims to explore the mechanism underlying urolithin C (UC)-mediated regulation of β-cell function.
- Survey Finds Widespread Perceived Inequities in Care for Adults with Sickle Cell Diseasehttps://reachmd.com/news/survey-finds-widespread-perceived-inequities-in-care-for-adults-with-sickle-cell-disease/2484532/An international survey study has highlighted significant disparities in perceived healthcare experiences among adults living with sickle cell disease (SCD) and recurrent vaso-occlusive crise